Golden Throat Holdings is one of the leading throat lozenges manufacturers in China. It has an eye-catching dividend yield (17.9% in 2023) and a blistering DPS growth (10x from 2020 to 2023).
What is covered in the Full Insight:
Golden Throat Holdings Overview
Conclusion and Investment Potential
Finding Golden Throat Holdings and Market Positioning
Company Background and Key Financials
Major Risk Factors and Considerations
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.